Lgl2 executes its function as a tumor suppressor by regulating ErbB signaling in the zebrafish epidermis

PLoS Genetics

Volumn 5, Issue 11, 2009, Pages

  Reischauer, Sven ^a   Levesque, Mitchell P ^a   Nüsslein Volhard, Christiane ^a   Sonawane, Mahendra ^a,b  

^a MAX PLANCK INSTITUTE FOR DEVELOPMENTAL BIOLOGY   (Germany)

^b TATA INSTITUTE OF FUNDAMENTAL RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

UVOMORULIN; ONCOPROTEIN; PENNER PROTEIN, ZEBRAFISH; TUMOR SUPPRESSOR PROTEIN; ZEBRAFISH PROTEIN;

ANIMAL TISSUE; ARTICLE; CARCINOMA; CONTROLLED STUDY; DOWN REGULATION; EPIDERMIS; EPIDERMIS CELL; EPITHELIUM; GENE EXPRESSION REGULATION; GENE FUNCTION; LGL2 GENE; MESENCHYME; MUTANT; NONHUMAN; ONCOGENE NEU; PHENOTYPE; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; SKIN TUMOR; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; ZEBRA FISH; ANIMAL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SHAPE; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOHISTOCHEMISTRY; LARVA; MESODERM; METABOLISM; MUTATION; PHYLOGENY; PHYSIOLOGY;

DANIO RERIO; GASTROPODA; MAMMALIA; VERTEBRATA;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SHAPE; EPIDERMIS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; IMMUNOHISTOCHEMISTRY; LARVA; MESODERM; MUTATION; ONCOGENE PROTEINS V-ERBB; PHYLOGENY; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS; ZEBRAFISH; ZEBRAFISH PROTEINS;

EID: 73649126176     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1000720     Document Type: Article

References (74)

1. Gateff E, Schneiderman HA (1967) Developmental studies of a new mutant of Drosophila melanogaster: Lethal malignant brain tumor (l(2)gl 4. American Zoologist 7: 760.
2. Gateff E SH (1974) Developmental Capacities of Benign and Malignant Neoplasms of Drosophila. Rouxs Arch Dev 176: 23-65.
3. Watson KL, Justice RW, Bryant PJ (1994) Drosophila in cancer research: the first fifty tumor suppressor genes. J Cell Sci Suppl 18: 19-33.
4. Woodhouse E, Hersperger E, Shearn A (1998) Growth, metastasis, and invasiveness of Drosophila tumors caused by mutations in specific tumor suppressor genes. Dev Genes Evol 207: 542-550.
5. Gateff E (1978) Malignant neoplasms of genetic origin in Drosophila melanogaster. Science 200: 1448-1459.
6. Gonzalez C (2007) Spindle orientation, asymmetric division and tumour suppression in Drosophila stem cells. Nat Rev Genet 8: 462-472.
7. Ohshiro T, Yagami T, Zhang C, Matsuzaki F (2000) Role of cortical tumour-suppressor proteins in asymmetric division of Drosophila neuroblast. Nature 408: 593-596.
8. Peng CY, Manning L, Albertson R, Doe CQ (2000) The tumour-suppressor genes lgl and dlg regulate basal protein targeting in Drosophila neuroblasts. Nature 408: 596-600.
9. Betschinger J, Mechtler K, Knoblich JA (2003) The Par complex directs asymmetric cell division by phosphorylating the cytoskeletal protein Lgl. Nature 422: 326-330.
10. Woodhouse EC, Fisher A, Bandle RW, Bryant-Greenwood B, Charboneau L, et al. (2003) Drosophila screening model for metastasis: Semaphorin 5c is required for l(2)gl cancer phenotype. Proc Natl Acad Sci U S A 100: 11463-11468.
11. Bilder D, Li M, Perrimon N (2000) Cooperative regulation of cell polarity and growth by Drosophila tumor suppressors. Science 289: 113-116.
12. Tanentzapf G, Tepass U (2003) Interactions between the crumbs, lethal giant larvae and bazooka pathways in epithelial polarization. Nat Cell Biol 5: 46-52.
13. Bilder D, Schober M, Perrimon N (2003) Integrated activity of PDZ protein complexes regulates epithelial polarity. Nat Cell Biol 5: 53-58.
14. Perrimon N (1988) The maternal effect of lethal(1)discs-large-1: a recessive oncogene of Drosophila melanogaster. Dev Biol 127: 392-407.
15. Mechler BM, McGinnis W, Gehring WJ (1985) Molecular cloning of lethal(2)giant larvae, a recessive oncogene of Drosophila melanogaster. Embo J 4: 1551-1557.
16. Bilder D, Perrimon N (2000) Localization of apical epithelial determinants by the basolateral PDZ protein Scribble. Nature 403: 676-680.
17. Klezovitch O, Fernandez TE, Tapscott SJ, Vasioukhin V (2004) Loss of cell polarity causes severe brain dysplasia in Lgl1 knockout mice. Genes Dev 18: 559-571.
18. Kuphal S, Wallner S, Schimanski CC, Bataille F, Hofer P, et al. (2006) Expression of Hugl-1 is strongly reduced in malignant melanoma. Oncogene 25: 103-110.
19. Tsuruga T, Nakagawa S, Watanabe M, Takizawa S, Matsumoto Y, et al. (2007) Loss of Hugl-1 expression associates with lymph node metastasis in endometrial cancer. Oncol Res 16: 431-435.
20. Sonawane M, Carpio Y, Geisler R, Schwarz H, Maischein HM, et al. (2005) Zebrafish penner/lethal giant larvae 2 functions in hemidesmosome formation, maintenance of cellular morphology and growth regulation in the developing basal epidermis. Development 132: 3255-3265.
21. Sonawane M, Martin-Maischein H, Schwarz H, Nusslein-Volhard C (2009) Lgl2 and E-cadherin act antagonistically to regulate hemidesmosome formation during epidermal development in zebrafish. Development.
22. Spaderna S, Schmalhofer O, Wahlbuhl M, Dimmler A, Bauer K, et al. (2008) The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer. Cancer Res 68: 537-544.
23. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100: 57-70.
24. Rajkumar T (2001) Growth factors and growth factor receptors in cancer. Current Science 81: 535-541.
25. Lee M, Vasioukhin V (2008) Cell polarity and cancer-cell and tissue polarity as a non-canonical tumor suppressor. J Cell Sci 121: 1141-1150.
26. Hsu MY, Meier FE, Nesbit M, Hsu JY, Van Belle P, et al. (2000) E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. Am J Pathol 156: 1515-1525.
27. Peinado H, Olmeda D, Cano A (2007) Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 7: 415-428.
28. Lee JM, Dedhar S, Kalluri R, Thompson EW (2006) The epithelial- mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 172: 973-981.
29. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, et al. (1998) p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 2: 305-316.
30. Akgul B, Pfefferle R, Marcuzzi GP, Zigrino P, Krieg T, et al. (2006) Expression of matrix metalloproteinase (MMP)-2, MMP-9, MMP-13, and MT1-MMP in skin tumors of human papillomavirus type 8 transgenic mice. Exp Dermatol 15: 35-42.
31. Hua J, Muschel RJ (1996) Inhibition of matrix metalloproteinase 9 expression by a ribozyme blocks metastasis in a rat sarcoma model system. Cancer Res 56: 5279-5284.
32. Sehgal G, Hua J, Bernhard EJ, Sehgal I, Thompson TC, et al. (1998) Requirement for matrix metalloproteinase-9 (gelatinase B) expression in metastasis by murine prostate carcinoma. Am J Pathol 152: 591-596.
33. Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, et al. (2000) The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2: 84-89.
34. Carl TF, Dufton C, Hanken J, Klymkowsky MW (1999) Inhibition of neural crest migration in Xenopus using antisense slug RNA. Dev Biol 213: 101-115.
35. Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, et al. (2000) The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2: 76-83.
36. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, et al. (1989) Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244: 707-712.
37. McKay MM, Morrison DK (2007) Integrating signals from RTKs to ERK/MAPK. Oncogene 26: 3113-3121.
38. Citri A, Yarden Y (2006) EGF-ERBB signalling: towards the systems level. Nat Rev Mol Cell Biol 7: 505-516.
39. Lyons DA, Pogoda HM, Voas MG, Woods IG, Diamond B, et al. (2005) erbb3 and erbb2 are essential for schwann cell migration and myelination in zebrafish. Curr Biol 15: 513-524.
40. Rojas-Munoz A, Rajadhyksha S, Gilmour D, van Bebber F, Antos C, et al. (2009) ErbB2 and ErbB3 regulate amputation-induced proliferation and migration during vertebrate regeneration. Dev Biol 327: 177-190.
41. van Bebber F (2005) Neural crest mutants and the effect of glia during differentiation in the zebrafish. PhD Thesis, University of Tübingen.
42. Budi EH, Patterson LB, Parichy DM (2008) Embryonic requirements for ErbB signaling in neural crest development and adult pigment pattern formation. Development 135: 2603-2614.
43. Goishi K, Lee P, Davidson AJ, Nishi E, Zon LI, et al. (2003) Inhibition of zebrafish epidermal growth factor receptor activity results in cardiovascular defects. Mech Dev 120: 811-822.
44. Nolan ME, Aranda V, Lee S, Lakshmi B, Basu S, et al. (2008) The polarity protein Par6 induces cell proliferation and is overexpressed in breast cancer. Cancer Res 68: 8201-8209.
45. Humbert PO, Grzeschik NA, Brumby AM, Galea R, Elsum I, et al. (2008) Control of tumourigenesis by the Scribble/Dlg/Lgl polarity module. Oncogene 27: 6888-6907.
46. Alpaugh ML, Tomlinson JS, Shao ZM, Barsky SH (1999) A novel human xenograft model of inflammatory breast cancer. Cancer Res 59: 5079-5084.
47. Charafe-Jauffret E, Tarpin C, Bardou VJ, Bertucci F, Ginestier C, et al. (2004) Immunophenotypic analysis of inflammatory breast cancers: identification of an 'inflammatory signature'. J Pathol 202: 265-273.
48. Kleer CG, van Golen KL, Braun T, Merajver SD (2001) Persistent E-cadherin expression in inflammatory breast cancer. Mod Pathol 14: 458-464.
49. Lanigan F, McKiernan E, Brennan DJ, Hegarty S, Millikan RC, et al. (2009) Increased claudin-4 expression is associated with poor prognosis and high tumour grade in breast cancer. Int J Cancer 124: 2088-2097.
50. Sobel G, Paska C, Szabo I, Kiss A, Kadar A, et al. (2005) Increased expression of claudins in cervical squamous intraepithelial neoplasia and invasive carcinoma. Hum Pathol 36: 162-169.
51. Tokes AM, Kulka J, Paku S, Szik A, Paska C, et al. (2005) Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study. Breast Cancer Res 7: R296-305.
52. Qin Y, Capaldo C, Gumbiner BM, Macara IG (2005) The mammalian Scribble polarity protein regulates epithelial cell adhesion and migration through E-cadherin. J Cell Biol 171: 1061-1071.
53. Tunggal JA, Helfrich I, Schmitz A, Schwarz H, Gunzel D, et al. (2005) E-cadherin is essential for in vivo epidermal barrier function by regulating tight junctions. Embo J 24: 1146-1156.
54. Tinkle CL, Lechler T, Pasolli HA, Fuchs E (2004) Conditional targeting of E-cadherin in skin: insights into hyperproliferative and degenerative responses. Proc Natl Acad Sci U S A 101: 552-557.
55. Tinkle CL, Pasolli HA, Stokes N, Fuchs E (2008) New insights into cadherin function in epidermal sheet formation and maintenance of tissue integrity. Proc Natl Acad Sci U S A 105: 15405-15410.
56. Onder TT, Gupta PB, Mani SA, Yang J, Lander ES, et al. (2008) Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 68: 3645-3654.
57. Sanceau J, Truchet S, Bauvois B (2003) Matrix metalloproteinase-9 silencing by RNA interference triggers the migratory-adhesive switch in Ewing's sarcoma cells. J Biol Chem 278: 36537-36546.
58. Symowicz J, Adley BP, Gleason KJ, Johnson JJ, Ghosh S, et al. (2007) Engagement of collagen-binding integrins promotes matrix metalloproteinase-9- dependent E-cadherin ectodomain shedding in ovarian carcinoma cells. Cancer Res 67: 2030-2039.
59. Murray JT, Campbell DG, Morrice N, Auld GC, Shpiro N, et al. (2004) Exploitation of KESTREL to identify NDRG family members as physiological substrates for SGK1 and GSK3. Biochem J 384: 477-488.
60. Kachhap SK, Faith D, Qian DZ, Shabbeer S, Galloway NL, et al. (2007) The N-Myc down regulated Gene1 (NDRG1) Is a Rab4a effector involved in vesicular recycling of E-cadherin. PLoS ONE 2: e844. doi:10.1371/journal.pone.0000844.
61. Wang Z, Sandiford S, Wu C, Li SS (2009) Numb regulates cell-cell adhesion and polarity in response to tyrosine kinase signalling. Embo J 28: 2360-2373.
62. Falcioni R, Antonini A, Nistico P, Di Stefano S, Crescenzi M, et al. (1997) Alpha 6 beta 4 and alpha 6 beta 1 integrins associate with ErbB-2 in human carcinoma cell lines. Exp Cell Res 236: 76-85.
63. Folgiero V, Bachelder RE, Bon G, Sacchi A, Falcioni R, et al. (2007) The alpha6beta4 integrin can regulate ErbB-3 expression: implications for alpha6-beta4 signaling and function. Cancer Res 67: 1645-1652.
64. Gambaletta D, Marchetti A, Benedetti L, Mercurio AM, Sacchi A, et al. (2000) Cooperative signaling between alpha(6)beta(4) integrin and ErbB-2 receptor is required to promote phosphatidylinositol 3-kinase-dependent invasion. J Biol Chem 275: 10604-10610.
65. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, et al. (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177-182.
66. Hicks DG, Kulkarni S (2008) HER2+ breast cancer: review of biologic relevance and optimal use of diagnostic tools. Am J Clin Pathol 129: 263-273.
67. Aranda V, Haire T, Nolan ME, Calarco JP, Rosenberg AZ, et al. (2006) Par6-aPKC uncouples ErbB2 induced disruption of polarized epithelial organization from proliferation control. Nat Cell Biol 8: 1235-1245.
68. Balciunas D, Wangensteen KJ, Wilber A, Bell J, Geurts A, et al. (2006) Harnessing a High Cargo-Capacity Transposon for Genetic Applications in Vertebrates. PLoS Genet 2: e169. doi:10.1371/journal.pgen.0020169.
69. Koster RW, Fraser SE (2001) Tracing transgene expression in living zebrafish embryos. Dev Biol 233: 329-346.
70. Smyth GK (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: Article3.
71. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5.
72. Benjamini Y, Hochberg Y (1995) Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing.
73. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
74. Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.